WORLD BIOBANKING SUMMIT

The global biobanking market was USD 142 million in 2011 and it is forecasted that this market will reach USD 216.3 million in 2018 with the compound annual growth rate of 5.4 % from 2011 – 2018. Moreover, the biobanking market witnessed an increased trend of mergers and acquisitions among vendors. This summit will address the latest developments in biobanking from its discovery to commercialization. It is one of the most important opportunities, where you will explore your business potential in biobanking. The U.S and Europe have the largest market size in biobanks. However, the rapid growth in population in Asia Pacific countries will affect the market of the developed countries. This summit will bring together experts from all levels of the value chain to analyze and tackle the latest and greatest opportunities in biobanking. The summit ensures maximum knowledge transfer among professionals and decision makers to exchange and elaborate on the best practices and explore business partnership opportunities.

KEY TOPICS

Quality management system in biobanking

Latest technological developments in biobanking

Strategic Partnerships for Biobanking – Challenges and Opportunities

Biobanking In Emerging Markets – Regulatory and Commercial Considerations

Biostatistics and data management

Cloud-Based Sample Management

Biobanking discovery to commercialization

Automated biobanking

Biobanks in clinical and translational research

WHY YOU SHOULD BE HERE?

Network with business development and licensing professionals as well as professionals in your sector

Implement the latest innovations

Learn about the latest technologies and most pressing topics specific to your business

Meet with experts and influencers in your industry face to face

Get an overview on innovative emerging technologies and explore your business potential

Interact and connect with leading companies and their representatives

Discuss about new opportunities for your products and services with key decision makers

Get new tips, tactics and implement the latest innovations

FEATURED SPEAKERS

Mag. Dr. Helmuth Haslacher, BSc BA

Biobank-Coordinator, QM-Coordinator
MedUni Wien Biobank

    Peadar Mac Gabhann

    Managing Director
    Biostór Ireland

    Dr. Balwir Matharoo-Ball

    President of ESBB & Deputy Director
    Nottingham Health Science Biobank

      Dr. Rita T. Lawlor, PhD

      Biobank Director
      ARC-Net Center for Applied Research on Cancer

        Paul Lomax

        Product Manager
        TTP Labtech

          Robert Hewitt, MB BS, PhD

          Director Biobank Consortia and Communications
          Trans-Hit Biomarkers Inc.

          Dr. Dejun Tang

          Global Head of Biostatistics & Clinical Submission Management
          Sandoz, a Novartis Division

            Prof. Jens K. Habermann, M.D., Ph.D.

            President of ESBB & Director
            Interdisciplinary Center for Biobanking-Lübeck

              Isabel Gil Aldea, MD, PhD

              Biobank Scientific Director
              NAVARRABIOMED

                Mark Divers, PhD

                Executive Director
                Karolinska Institutet Biobank

                  Audrey Schenker

                  LIMS Application Engineer, Biobank Specialist
                  Genohm SA, a part of Agilent Technologies Inc.
                    Close

                    FEATURED COMPANIES

                    SPONSORS

                    MEDIA PARTNERS

                    Dr. Robert Hewitt, Chair Person, World Biobanking Summit









                      GREAT OFFERS, RIGHT IN YOUR INBOX!

                      Subscribe to our newsletter and get up-to-date information regarding the ``WORLD BIOBANKING SUMMIT``

                      Events | Terms and Conditions | Privacy Policy | Cookies Policy | Careers

                      Copyright 2018 © Sharonat Group s.r.o. All rights reserved.

                      Send